Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Safety Study of Subjects Exposed to Ibrexafungerp Whilst Pregnant, Including Infant Outcomes Up to One Year

NCT05908682 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT05908682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05908682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Safety Study of Subjects Exposed to Ibrexafungerp Whilst Pregnant, Including Infant Outcomes Up to One Year
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Recruiting
Start date
November 12, 2025
Completion date
July 31, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

candida infection, vaginal candidiasis, vulvovaginal candidiasis, vulvovaginitis, candidal